Mesangial proliferative glomerulonephritis in murine malaria parasite, Plasmodium chabaudi AS, infected NC mice.
Yashima A, Mizuno M, Yuzawa Y, Shimada K, Suzuki N, Tawada H, Sato W, Tsuboi N, Maruyama S, Ito Y, Matsuo S, Ohno T.
Clin Exp Nephrol. 2017 Aug;21(4):589-596. doi: 10.1007/s10157-016-1339-8. Epub 2016 Nov 4.
Childhood nephrotic syndrome in tropical Africa: then and now.
Olowu WA, Ademola A, Ajite AB, Saad YM.
Paediatr Int Child Health. 2017 Nov;37(4):259-268. doi: 10.1080/20469047.2017.1374002. Epub 2017 Sep 26.
Childhood Nephrotic Syndrome in Africa: Epidemiology, Treatment Trends, and Outcomes.
Ademola AD, Asinobi AO, Alao MA, Olowu WA.
Semin Nephrol. 2022 Sep;42(5):151311. doi: 10.1016/j.semnephrol.2023.151311. Epub 2023 Mar 9.
Nephrotic syndrome in monkey infected with human quartan malaria.
Voller A, Draper CC, Shwe T, Hutt MS.
Br Med J. 1971 Oct 23;4(5781):208-10. doi: 10.1136/bmj.4.5781.208.
Glomerulonephropathies in Plasmodium inui-infected rhesus monkey: a primate model and possible applications for human quartan malaria.
Nimri LF, Lanners HN.
Parasitology. 2014 Jul 15:1-8. doi: 10.1017/S0031182014000900. Online ahead of print.
Malaria prophylaxis and immunosuppressant therapy in management of nephrotic syndrome associated with quartan malaria.
Kibukamusoke JW.
Arch Dis Child. 1968 Oct;43(231):598-600. doi: 10.1136/adc.43.231.598.
Evidence for soluble immune complexes in the pathogenesis of the glomerulonephritis of quartan malaria.
Ward PA, Kibukamusoke JW.
Lancet. 1969 Feb 8;1(7589):283-5. doi: 10.1016/s0140-6736(69)91038-1.
End-stage renal disease in Nigeria: an overview of the epidemiology and the pathogenetic mechanisms.
Odubanjo MO, Okolo CA, Oluwasola AO, Arije A.
Saudi J Kidney Dis Transpl. 2011 Sep;22(5):1064-71.
Glomerulonephritis in common marmosets infected with Plasmodium brasilianum and Epstein-Barr virus.
Wedderburn N, Davies DR, Mitchell GH, Desgranges C, de Thé G.
J Infect Dis. 1988 Oct;158(4):789-94. doi: 10.1093/infdis/158.4.789.
Therapy of membranous nephropathy associated with malignancy and secondary causes.
Jefferson JA, Couser WG.
Semin Nephrol. 2003 Jul;23(4):400-5. doi: 10.1016/s0270-9295(03)00055-x.
